Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Featuring Abivax S.A., F. Hoffmann-La Roche, Gilead Sciences, Transgene & VLP Biotech - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016" report to their offering.

'Hepatitis B Virus Core Antigen - Pipeline Review, H1 2016' Hepatitis B Virus Core Antigen (HBcAg) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies.

Furthermore, the author says, Hepatitis B Virus Core Antigen (HBcAg) HBcAg (core antigen) is a hepatitis B viral protein. It plays an important role in viral replication. It is found on the surface of the nucleocapsid core of hepatitis B virus.

The report 'Hepatitis B Virus Core Antigen - Pipeline Review, H1 2016' outlays comprehensive information on the Hepatitis B Virus Core Antigen (HBcAg) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type that are being developed by Companies / Universities.

It also reviews key players involved in Hepatitis B Virus Core Antigen (HBcAg) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Currently, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 2 and 1 respectively.

Key Topics Covered:

  1. Introduction
  2. Hepatitis B Virus Core Antigen Overview
  3. Therapeutics Development
  4. Pipeline Products for Hepatitis B Virus Core Antigen - Overview
  5. Pipeline Products for Hepatitis B Virus Core Antigen - Comparative Analysis
  6. Hepatitis B Virus Core Antigen - Therapeutics under Development by Companies
  7. Hepatitis B Virus Core Antigen - Therapeutics under Investigation by Universities/Institutes
  8. Hepatitis B Virus Core Antigen Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Hepatitis B Virus Core Antigen - Products under Development by Companies
  13. Hepatitis B Virus Core Antigen - Products under Investigation by Universities/Institutes
  14. Hepatitis B Virus Core Antigen - Companies Involved in Therapeutics Development
  • Abivax S.A.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Transgene SA
  • VLP Biotech, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/w8psfg/hepatitis_b_virus

Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716